World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
90
Citations
51736
World Ranking
11964
National Ranking
6130

Stanley J. Wiegand publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Stanley J. Wiegand sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 249 publications — 8th percentile

8% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Stanley J. Wiegand D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Stanley J. Wiegand sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 90 D-Index — 41st percentile

41% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Stanley J. Wiegand is affiliated with Regeneron in the United States. Their professional background is primarily connected to this institution, which is notable in the biomedical and pharmaceutical research sectors.

There is no available data on recent papers authored by Stanley J. Wiegand, which limits insight into their specific research topics, publication history, and impact metrics such as citations.

No frequent co-authors have been identified in the available information, indicating either a limited publication record or a lack of linked collaborative networks in publicly indexed datasets.

The data does not provide any details about frequent publication venues, which means the typical journals or conferences where this scientist publishes their work remain unspecified.

Similarly, there is no information on book publications or associations with specific publishers connected to Stanley J. Wiegand.

The scientist's main fields of study and subfields of study are not listed, so their precise areas of scientific inquiry cannot be outlined from the current data.

Details regarding specific main topics of research or specialized areas within their work are also absent.

There are no recorded awards or honors attributed to Stanley J. Wiegand in the data provided, including the years when any such recognitions might have been received.

Best Publications

  • Vascular-specific growth factors and blood vessel formation

    George D. Yancopoulos;Samuel Davis;Nicholas W. Gale;John S. Rudge

  • Angiopoietin-2, a Natural Antagonist for Tie2 That Disrupts in vivo Angiogenesis

    Peter C. Maisonpierre;Chitra Suri;Pamela F. Jones;Sona Bartunkova

  • Vessel Cooption, Regression, and Growth in Tumors Mediated by Angiopoietins and VEGF

    J. Holash;P. C. Maisonpierre;D. Compton;P. Boland

  • VEGF-Trap: A VEGF blocker with potent antitumor effects

    Jocelyn Holash;Sam Davis;Nick Papadopoulos;Susan D. Croll

  • NT-3, BDNF, and NGF in the developing rat nervous system: parallel as well as reciprocal patterns of expression.

    Peter C. Maisonpierre;Leonardo Belluscio;Beth Friedman;Ralph F. Alderson

  • Infusion of Brain-Derived Neurotrophic Factor into the Lateral Ventricle of the Adult Rat Leads to New Neurons in the Parenchyma of the Striatum, Septum, Thalamus, and Hypothalamus

    Viorica Pencea;Kimberly D. Bingaman;Stanley J. Wiegand;Marla B. Luskin

  • Anterograde transport of brain-derived neurotrophic factor and its role in the brain.

    C A Altar;N Cai;T Bliven;M Juhasz

  • VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment

    Claus Cursiefen;Lu Chen;Leonardo P. Borges;David Jackson

  • Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1.

    Nicholas W. Gale;Gavin Thurston;Sean F. Hackett;Roumiana Renard

  • Antidepressant-Like Effect of Brain-derived Neurotrophic Factor (BDNF)

    Judith A Siuciak;Dacie R Lewis;Stanley J Wiegand;Ronald M Lindsay

  • Neurotrophic factors: from molecule to man.

    Ronald M. Lindsay;Stanley J. Wiegand;C. Anthony Altar;Peter S. DiStefano

  • Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab

    Nicholas Papadopoulos;Joel Martin;Qin Ruan;Ashique Rafique

  • New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF.

    J Holash;S J Wiegand;G D Yancopoulos

  • Delta-like ligand 4 (Dll4) is induced by VEGF as a negative regulator of angiogenic sprouting.

    I. B. Lobov;R. A. Renard;N. Papadopoulos;N. W. Gale

  • The neurotrophins BDNF, NT-3, and NGF display distinct patterns of retrograde axonal transport in peripheral and central neurons

    Peter S. DiStefano;Beth Friedman;Czeslaw Radziejewski;Charles Alexander

  • Intraventricular Administration of BDNF Increases the Number of Newly Generated Neurons in the Adult Olfactory Bulb

    Tanja Zigova;Viorica Pencea;Stanley J. Wiegand;Marla B. Luskin

  • Genetic deletion of ghrelin does not decrease food intake but influences metabolic fuel preference.

    Katherine E. Wortley;Keith D. Anderson;Karen Garcia;Jane D. Murray

  • BDNF and NT-4/5 Prevent Atrophy of Rat Rubrospinal Neurons after Cervical Axotomy, Stimulate GAP-43 and Tα1-Tubulin mRNA Expression, and Promote Axonal Regeneration

    Nao R. Kobayashi;Da-Peng Fan;Klaus M. Giehl;Annie M. Bedard

  • Neuronal deficits, not involving motor neurons, in mice lacking BDNF and/or NT4.

    J. C. Conover;J. T. Erickson;David M Katz;L. M. Bianchi

  • The α component of the CNTF receptor is required for signaling and defines potential CNTF targets in the adult and during development

    Nancy Y. Ip;Joyce McClain;Nestor X. Barrezueta;Thomas H. Aldrich

Frequent Co-Authors

George D. Yancopoulos
George D. Yancopoulos Regeneron (United States)
Ronald M. Lindsay
Ronald M. Lindsay Zebra Biologics (United States)
Claus Cursiefen
Claus Cursiefen University of Cologne
Nicholas W. Gale
Nicholas W. Gale Regeneron (United States)
Andrew J. Murphy
Andrew J. Murphy St. Jude Children's Research Hospital
Nancy Y. Ip
Nancy Y. Ip Hong Kong University of Science and Technology
Peter A. Campochiaro
Peter A. Campochiaro Johns Hopkins University School of Medicine
David Zagzag
David Zagzag New York University
Reza Dana
Reza Dana Massachusetts Eye and Ear Infirmary

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a career in Medicine or healthcare, there are several flexible and diverse educational pathways you can explore online. For registered nurses seeking career advancement, an rn to bsn online with no clinicals program can help you earn a BSN degree while balancing work and personal commitments, as these programs eliminate traditional on-site clinical requirements.

Those aiming for the highest level of clinical nursing may consider the fastest dnp online program options, which offer an accelerated path to a Doctor of Nursing Practice degree. Additionally, if you seek a more manageable workload, the easiest dnp programs can provide a less rigorous academic route without sacrificing quality or accreditation.

Entry-level pathways are also available, such as lpn programs that help you quickly start your healthcare career as a Licensed Practical Nurse. Online learning offers unmatched flexibility, making it possible to transition or advance in various medical fields regardless of your current career stage.

Best Scientists Citing Stanley J. Wiegand

Trending Scientists

Recently Published Articles